Mediators of Inflammation / 2013 / Article / Tab 3

Clinical Study

Inflammation, Haemostatic Disturbance, and Obesity: Possible Link to Pathogenesis of Diabetic Retinopathy in Type 2 Diabetes

Table 3

Differences in C-reactive protein, fibrinogen, , total cholesterol, and triglycerides in type 2 diabetic patients divided into three groups according to the diabetic retinopathy status and the level of obesity defined by BMI, WC, and WHR.

CRPFibrinogen Total cholest.Triglycerides
df

BMI 3 groups10.6600.41840.0030.95882.8770.09306.7340.01096.3530.0133
DR11.7110.19390.1570.69274.7760.03121.1320.28990.9860.3231
BMI 3 gr. * DR30.3350.79970.8780.45521.2310.30250.9380.42542.1970.0932

WC 3 groups15.0770.02651.2870.25930.7630.38460.0100.92170.6760.4130
DR12.3950.12490.6620.41803.4790.06510.2680.60570.8910.3476
WC 3 gr. * DR30.3200.81081.9710.12330.1420.93450.5330.66041.0630.3686

WHR 3 groups22.5360.08444.8090.01020.7900.45661.6660.19431.6970.1885
DR22.1630.12041.1980.30632.8750.06120.6580.52001.7950.1716
WHR 3 gr. * DR41.6390.17041.0610.37991.7690.14110.3410.84991.0090.4065

DR: diabetic retinopathy; BMI: body mass index (kg/m²); WC: waist circumference (cm); WHR: waist-to-hip ratio; CRP: C-reactive protein; : glycated hemoglobin value obtained by statistical analysis of data from the National Registry for Diabetes (CroDiabNet).

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.